Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia: A systematic review and network meta-analysis of randomized controlled trials

Jing Xu; Kang Wu; Xiao Li; Chiah Shean Teo; Guangda Li; Yiming Pan; Li Hou

doi:10.1016/j.jtcms.2023.03.004

您当前的位置：

首页 >

文章列表页 >

Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia: A systematic review and network meta-analysis of randomized controlled trials

Full-length article | 更新时间：2023-05-16

- Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia: A systematic review and network meta-analysis of randomized controlled trials
- Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia: A systematic review and network meta-analysis of randomized controlled trials
- Genes & Diseases 2023年10卷第2期
- 作者机构：
  
  1. Institut Kanser Negara, Ministry of Health Malaysia, Putrajaya,Malaysia,62250
  2. First School of Clinical Medicine, Beijing University of Chinese Medicine,Beijing,China,100029
  3. Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicine,Beijing,China,100700
- 作者简介：
- 基金信息：
- DOI：10.1016/j.jtcms.2023.03.004
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-4-1，
扫描看全文
Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia: A systematic review and network meta-analysis of randomized controlled trials[J]. Genes & Diseases, 2023,10(2).

Jing Xu, Kang Wu, Xiao Li, et al. Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia: A systematic review and network meta-analysis of randomized controlled trials[J]. Genes & Diseases, 2023,10(2).
Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia: A systematic review and network meta-analysis of randomized controlled trials[J]. Genes & Diseases, 2023,10(2). DOI： 10.1016/j.jtcms.2023.03.004.

Jing Xu, Kang Wu, Xiao Li, et al. Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia: A systematic review and network meta-analysis of randomized controlled trials[J]. Genes & Diseases, 2023,10(2). DOI： 10.1016/j.jtcms.2023.03.004.

摘要

Abstract

ObjectiveTo evaluate the effectiveness and safety of seven oral Chinese patent medicines (CPMs) as adjuvant therapy for cancer-related anemia (CRA) by network meta-analysis (NMA).

关键词

Keywords

Cancer-related anemiaChinese patent medicineNetwork meta-analysisEffectivenessSafety

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据